Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2564877167;77168;77169 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
N2AB2400772244;72245;72246 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
N2A2308069463;69464;69465 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
N2B1658349972;49973;49974 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
Novex-11670850347;50348;50349 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
Novex-21677550548;50549;50550 chr2:178569190;178569189;178569188chr2:179433917;179433916;179433915
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAT
  • RefSeq wild type template codon: ATA
  • Domain: Fn3-74
  • Domain position: 48
  • Structural Position: 65
  • Q(SASA): 0.2213
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/H rs376340301 -1.198 0.999 N 0.735 0.457 None gnomAD-2.1.1 4.08E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.98E-06 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.95 likely_pathogenic 0.9574 pathogenic -2.428 Highly Destabilizing 0.999 D 0.638 neutral None None None None N
Y/C 0.6613 likely_pathogenic 0.7173 pathogenic -0.945 Destabilizing 1.0 D 0.709 prob.delet. N 0.461944128 None None N
Y/D 0.9445 likely_pathogenic 0.9466 pathogenic -0.771 Destabilizing 1.0 D 0.749 deleterious N 0.474501748 None None N
Y/E 0.9928 likely_pathogenic 0.9933 pathogenic -0.702 Destabilizing 0.999 D 0.707 prob.neutral None None None None N
Y/F 0.0739 likely_benign 0.0805 benign -1.207 Destabilizing 0.872 D 0.537 neutral N 0.438745795 None None N
Y/G 0.9549 likely_pathogenic 0.9585 pathogenic -2.717 Highly Destabilizing 0.999 D 0.711 prob.delet. None None None None N
Y/H 0.6881 likely_pathogenic 0.7227 pathogenic -0.943 Destabilizing 0.999 D 0.735 prob.delet. N 0.470742766 None None N
Y/I 0.9361 likely_pathogenic 0.9441 pathogenic -1.56 Destabilizing 0.976 D 0.736 prob.delet. None None None None N
Y/K 0.9941 likely_pathogenic 0.9946 pathogenic -0.991 Destabilizing 0.992 D 0.705 prob.neutral None None None None N
Y/L 0.8969 likely_pathogenic 0.9049 pathogenic -1.56 Destabilizing 0.854 D 0.587 neutral None None None None N
Y/M 0.9448 likely_pathogenic 0.9486 pathogenic -1.161 Destabilizing 1.0 D 0.737 prob.delet. None None None None N
Y/N 0.8496 likely_pathogenic 0.868 pathogenic -1.21 Destabilizing 1.0 D 0.718 prob.delet. N 0.474755237 None None N
Y/P 0.9669 likely_pathogenic 0.9724 pathogenic -1.844 Destabilizing 1.0 D 0.75 deleterious None None None None N
Y/Q 0.9857 likely_pathogenic 0.9873 pathogenic -1.244 Destabilizing 0.999 D 0.731 prob.delet. None None None None N
Y/R 0.9828 likely_pathogenic 0.9851 pathogenic -0.409 Destabilizing 0.998 D 0.717 prob.delet. None None None None N
Y/S 0.8528 likely_pathogenic 0.866 pathogenic -1.827 Destabilizing 0.999 D 0.715 prob.delet. N 0.509605815 None None N
Y/T 0.9611 likely_pathogenic 0.9657 pathogenic -1.671 Destabilizing 0.999 D 0.713 prob.delet. None None None None N
Y/V 0.891 likely_pathogenic 0.9027 pathogenic -1.844 Destabilizing 0.999 D 0.662 neutral None None None None N
Y/W 0.2562 likely_benign 0.274 benign -0.719 Destabilizing 0.378 N 0.3 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.